Jacaric acid is a conjugated linolenic acid, which inhibits viability in cells PC-3 (IC₅₀ is 11.8 μM), LNCaP (IC₅₀ is 2.2 μM) and DLD-1, induces apoptosis and necrosis^[1]. Jacaric acid exhibits anticaner activity against prostate cancer and adenocarcinoma^[2]. Jacaric acid exhibits immunomodulating activity in murine peritoneal macrophages as an immunopotentiator^[3]. Jacaric acid is orally active.